4 research outputs found

    An Evaluation Of 3-rhamnosylquercetin, A Glycosylated Form Of Quercetin, Against The Myotoxic And Edematogenic Effects Of Spla 2 From Crotalus Durissus Terrificus

    No full text
    This paper shows the results of quercitrin effects on the structure and biological activity of secretory phospholipase (sPLA2) from Crotalus durissus terrificus, which is the main toxin involved in the pharmacological effects of this snake venom. According to our mass spectrometry and circular dichroism results, quercetin was able to promote a chemical modification of some amino acid residues and modify the secondary structure of C. d. terrificus sPLA2. Moreover, molecular docking studies showed that quercitrin can establish chemical interactions with some of the crucial amino acid residues involved in the enzymatic activity of the sPLA2, indicating that this flavonoid could also physically impair substrate molecule access to the catalytic site of the toxin. Additionally, in vitro and in vivo assays showed that the quercitrin strongly diminished the catalytic activity of the protein, altered its Vmax and Km values, and presented a more potent inhibition of essential pharmacological activities in the C. d. terrificus sPLA2, such as its myotoxicity and edematogenic effect, in comparison to quercetin. Thus, we concluded that the rhamnose group found in quercitrin is most likely essential to the antivenom activities of this flavonoid against C. d. terrificus sPLA2. © 2014 Daniela de Oliveira Toyama et al

    Effects Of Morin On Snake Venom Phospholipase A2 (pla 2)

    No full text
    Flavonoids are potent anti-inflammatory compounds isolated from several plant extracts, and have been used experimentally against inflammatory processes. In this work, a PLA2 isolated from the Crotalus durissus cascavella venom and rat paw oedema were used as a model to study the effect of flavonoids on PLA2. We observed that a treatment of PLA2 with morin induces several modifications in the aromatic amino acids, with accompanying changes in its amino acid composition. In addition, results from circular dichroism spectroscopy and UV scanning revealed important structural modifications. Concomitantly, a considerable decrease in the enzymatic and antibacterial activities was observed, even though anti-inflammatory and neurotoxic activities were not affected. These apparent controversial results may be an indication that PLA2 possess a second pharmacological site which does not affect or depend on the enzymatic activity. © 2005 Elsevier Ltd. All rights reserved.467751758Bors, W., Heller, W., Michel, C., Saran, M., Flavonoids as anti-oxidants: Determination of radical-scavenging efficiencies (1990) Method. Enzymol., 186, pp. 343-355Cao, G., Verdon, C., Wu, A.H.B., Wang, H., Prior RL-Automated oxygen radical absorbance capacity assay using the COBAS FARA II (1995) Clin. Chem., 41, pp. 1738-1744Cao, G., Sofie, E., Prior, R.L., Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships (1997) Free Radic. Biol. Med., 22, pp. 749-760Chandra, V., Jasti, J., Kaur, P., Betzel, C., Srinivasan, A., Singh, T.P., First structural evidence of a specific inhibition of phospholipase A2 by α-Tocopherol (Vitamin E) and its implication in inflammation: Crystal structure of the complex formed between phospholipase A2 and α-Tocopherol at 1.8 Å resolution (2002) J. Mol. Biol., 320, pp. 215-222Di Carlo, G., Mascolo, N., Izzo, A.A., Capasso, F., Flavonoids: Old and new aspects of class of natural therapeutic drugs (1999) Life Sci., 65, pp. 337-353Fang, S.-H., Hou, Y.-C., Chang, W.-C., Hsiu, S.-L., Lee Chao, P.-D., Chiang, B.-L., Morin sulfates/ glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock (2003) Life Sci., 74 (6), pp. 743-756Fawzy, A.A., Vishwanath, B.S., Franson, R.C., Inhibition of human non-pancreatic phospholipase A2 by retinoids and flavonoids. Mechanism of action (1988) Agents Actions, 25 (3-4), pp. 394-400Gil, B., Sanz, J., Terencio, M.C., Gunasegaran, R., Payá, M., Alcazar, M.J., Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (1997) Biochem. Pharmacol., 53, pp. 733-743Ginsborg, B.L., Warriner, J., The isolated chick biventer cervicis nerve-muscle preparation (1960) Br. Pharm. Chemother., 15, pp. 410-421Harborne, J.B., (1988) The Flavonoids: Advances in Research, , Chapman & Hall LondonHodnick, W.F., Duval, D.L., Pardini, R.S., Inhibition of mithocondrial respiration and cyaned stimulated generation of reactive oxygen species by selected flavonoids (1994) Biochem. Pharmacol., 47 (3), pp. 573-580Holzer, M., MacKessy, S.P., An aqueous endpoint assay of snake venom phospholipase A2 (1996) Toxicon, 34 (10), pp. 1149-1155Kitagawa, S., Sakamoto, H., Tano, H., Inhibitory effect of flavonoids on free radical-induced hemolysis and ther oxidative effect on hemoglobin (2004) Chem. Pharm. Bull., 52 (8), pp. 999-1001Koduri, R.S., Grönrooss, J.O., Laine, V.J.O., Calvez, C.L., Lambeau, G., Nevelainen, T.J., Gelb, M.H., Bactericidal properties of human and murine groups I, II, V, X and XII secreted phospholipases A2 (2002) J. Biol. Chem., 277 (8), pp. 5849-5857Lindahl, M., Tagesson, C., Flavonoids as phospholipase A2 inhibitors: Importance of their structure for selective inhibition of group II phospholipase A2 (1997) Inflammation, 21 (3), pp. 347-356Middleton Jr., E., Drzewiecki, G., Flavonoid inhibition of human basophile histamine release stimulated by various agents (1984) Biochem. Pharmacol., 33, pp. 3333-3338Murakami, M., Shimbara, S., Kambe, T., Kuwata, H., Winstead, M.V., Tishifield, J.A., Kudo, I., The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release (1998) J. Biol. Chem., 273 (23), pp. 14411-14423Rice-Evans, C.A., Miller, N.J., Paganga, G., Structure antioxidant activity relationships of flavonoids and phenolic acids (1996) Free Radic. Biol. Med., 20, pp. 933-956Rotelli, A.E., Guardia, T., Juarez, A.O., De La Rocha, N.E., Pelzer, L.E., Comparative study of flavonoids in experimental models of inflammation (2003) Pharmacol. Res., 48, pp. 601-606Schagger, H., Von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa (1987) Anal. Biochem., 166 (2), pp. 368-379Takeda, A.A., Dos Santos, J.I., Marcussi, S., Silveira, L.B., Soares, A.M., Fontes, M.R., Crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A(2) complexed with p-bromophenacyl bromide and alpha-tocopherol inhibitors at 1.9- and 1.45-A resolution (2004) Biochim. Biophys. Acta., (1-2), pp. 281-284Teixeira, C.F., Landucci, E.C., Antunes, E., Chacur, M., Cury, Y., Inflammatory effects of snake venom myotoxic phospholipases A2 (2003) Toxicon, 42 (8), pp. 947-962Toyama, M.H., De Oliveira, D.G., Beriam, L.O., Novello, J.C., Rodrigues-Simioni, L., Marangoni, S., Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom (2003) Toxicon, 41 (8), pp. 1033-1038Valentin, E., Lambeau, G., Increasing molecular diversity of secreted phospholipases A2 and their receptor and binding proteins (2000) Biochim. Biophys. Acta, 1488, pp. 59-70Vishwanath, B.S., Fawzy, A.A., Franson, R.C., Edema-inducing activity of phospholipase A2 purified from synovial fluid and inhibition by aristolochic acid (1988) Inflammation, 12 (6), pp. 549-561Williams, C.N., Honet, J.R.S., Harborne, J.B., Greenham, J., Eeagles, J.A., Biologically active lipophilic flavonols from Tanacetum parthenium (1995) Phytochemistry, 38, pp. 267-270Xu, H., Ziegelin, G., Schroder, W., Frank, J., Ayora, S., Alonso, J.C., Lanka, E., Saenger, W., Flavones inhibit the hexameric replicative helicase RepA (2001) Nucleic Acids Res., 29 (24), pp. 5058-5066Zhao, H., Tang, L., Wang, X.-Q., Zhou, Y., Lin, Z., Structural of a snake venom phospholipase A2 modified by p-Bromophenacyl bromide (1998) Toxicon, 36 (6), pp. 875-88

    Crotacetin, A Novel Snake Venom C-type Lectin Homolog Of Convulxin, Exhibits An Unpredictable Antimicrobial Activity

    No full text
    Snake venom (sv) C-type lectins encompass a group of hemorrhagic toxins that are capable of interfering with blood stasis. A very well-studied svC-type lectin is the heterodimeric toxin, convulxin (CVX), from the venom of South American rattlesnake Crotalus durissus terrificus. CVX is able to activate platelets and induce their aggregation by acting via p62/GPVI collagen receptor. By using polymerase chain reaction homology screening, we have cloned several cDNA precursors of CVX subunit homologs. One of them, named crotacetin (CTC) β-subunit, predicts a polypeptide with a topology very similar to the tridimensional conformations of other subunits of CVX-like snake toxins, as determined by computational analysis. Using gel permeation and reverse-phase high-performance liquid chromatography, CTC was purified from C. durissus venoms. CTC can be isolated from the venom of several C. durissus subspecies, but its quantitative predominance is in the venom of C. durissus cascavella. Functional analysis indicates that CTC induces platelet aggregation, and, importantly, exhibits an antimicrobial activity against Gram-positive and -negative bacteria, comparable with CVX. © Copyright 2006 by Humana Press Inc. All rights of any nature whatsoever reserved.443412423Mukherjee, A.K., Maity, C.R., Biochemical composition, lethality and pathophysiology of venom from two cobras - Naja naja and N. kaouthia (2002) Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 131, pp. 125-132Daltry, J.C., Wüster, W., Thorpe, R.S., Diet and snake venom evolution (1996) Nature, 379, pp. 537-540Saravia, P., Rojas, E., Arce, V., Geographic and ontogenic variability in the venom of the Neotropical rattlesnake Crotalus durissus: Pathophysiological and therapeutic implications (2002) Rev. Biol. Trop., 50, pp. 337-346Shashidharamurthy, R., Jagadeesha, D.K., Girish, K.S., Kemparaju, K., Variations in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution (2002) Mol. Cell. Biochem., 229, pp. 93-101Lopez-Lozano, J.L., De Sousa, M.V., Ricart, C.A., Ontogenetic variation of metalloproteinases and plasma coagulant activity in venoms of wild Bothrops atrox specimens from Amazonian rain forest (2002) Toxicon, 40, pp. 997-1006Tsai, I.H., Wang, Y.M., Chen, Y.H., Tu, A.T., Geographic variations, cloning, and functional analyses of the venom acidic phospholipases A2 of Crotalus viridis viridis (2003) Arch. Biochem. Biophys., 411, pp. 289-296Harvey, A., (1993) Natural and Synthetic Neurotoxins, , Academic, New YorkMarkland, F.S., Snake venom and the hemostatic system (1998) Toxicon, 36, pp. 1749-1800Drickamer, K., C-type lectin-like domains (1999) Curr. Opin. Struct. Biol., 9, pp. 585-590Ogawa, T., Chijiwa, T., Oda-Ueda, N., Ohno, M., Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom (2005) Toxicon, 45, pp. 1-14Prado-Franceschi, J., Brazil, O.V., Convulxin, a new toxin from the venom of the South American rattlesnake Crotalus durissus terrificus (1981) Toxicon, 19, pp. 875-887Murakami, M.T., Zela, S.P., Gava, L.M., Michelan-Duarte, S., Cintra, A.C., Arni, R.K., Crystal structure of the platelet activator convulxin, a disulfide-linked alpha4beta4 cyclic tetramer from the venom of Crotalus durissus terrificus (2003) Biochem. Biophys. Res. Commun., 310, pp. 478-482Batuwangala, T., Leduc, M., Gibbins, J.M., Bon, C., Jones, E.Y., Structure of the snake-venom toxin convulxin (2004) Acta Crystallogr., 60, p. 46Polgar, J., Clemetson, J.M., Kehrel, B.E., Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor (1997) J. Biol. Chem., 272, pp. 13,576-13,583Hamako, J., Matsui, T., Suzuki, M., Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom (1996) Biochem. Biophys. Res. Commun., 226, pp. 273-279Fujimura, Y., Titani, K., Usami, Y., Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca (1991) Biochemistry, 30, pp. 1957-1964Fukuda, K., Mizuno, H., Atoda, H., Morita, T., Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers (2000) Biochemistry, 39, p. 1915Du, X.Y., Clemetson, J.M., Navdaev, A., Magnenat, E.M., Wells, T.N., Clemetson, K.J., Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI (2002) J. Biol. Chem., 277, pp. 35,124-35,132Huang, K.F., Ko, T.P., Hung, C.C., Chu, J., Wang, A.H., Chiou, S.H., Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus) (2004) Biochem. J., 378, pp. 399-407Furihata, K., Kato, K., Rádis-Baptista, G., Kunicki, T.J., Recombinant convulxin induces platelet aggregation (2003) Blood, 102, p. 2891Rottenberg, D., Bamberger, E.S., Kochva, E., Studies on ribonucleic acid synthesis in the venom glands of Vipera palaestinae (Ophidiae, Reptilia) (1971) Biochem. J., 121, pp. 609-612Rádis-Baptista, G., Oguiura, N., Hayashi, M.A.F., Nucleotide sequence of crotamine isoform precursors from a single South American rattlesnake (Crotalus durissus terrificus) (1999) Toxicon, 37, pp. 973-984Altschul, S.F., Madden, T.L., Schäffer, A.A., Gapped BLAST and PSI-BLAST: A new generation of protein database search programs (1997) Nucleic Acids Res., 25, pp. 3389-3402Higgins, D., Thompson, J., Gibson, T., Thompson, J.D., Higgins, D.G., Gibson, T.J., CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice (1994) Nucleic Acids Res., 22, pp. 4673-4680Uchoa, H.B., Jorge, G.E., Da Silveira, N.J.F., Câmera Jr., J.C., Canduri, F., De Azevedo, W.F.J., Parmodel: A web server for automated comparative modeling of proteins (2004) Biochem. Biophys. Res. Commun., 325, pp. 1481-1486Sali, A., Blundell, T.L., Comparative protein modeling by satisfaction of spatial restraints (1993) J. Mol. Biol., 234, pp. 779-815Laskowski, R.A., MacArthur, M.W., Moss, D.S., Thornton, J.M., PROCHECK: A program to check the stereochemical quality of protein structures (1993) J. Appl. Crystallogr., 26, pp. 283-291Hooft, R.W., Vriend, G., Sander, C., Abola, E.E., Errors in protein structures (1996) Nature, 381, pp. 83-85Bowie, J.U., Luthy, R., Eisenberg, D., A method to identify protein sequences that fold into a known three-dimensional structure (1991) Science, 253, pp. 164-170Ramakrishnan, C., Ramachandran, G.N., Stereochemical criteria for polypeptide and protein chain conformations. II. Allowed conformations for a pair of peptide units (1965) Biophys. J., 5, pp. 909-933Chudzinski-Tavassi, A.M., Bermej, E., Rosenstein, R.E., Nitridergic platelet pathway activation by hementerin, a metalloprotease from the leech Haementeria depressa (2003) Biol. Chem., 384, pp. 1333-1339Fry, B.G., Wauuster, W., Assembling an arsenal: Origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences (2004) Mol. Biol. Evol., 21, pp. 871-885Nakashima, K., Nobuhisa, I., Deshimaru, M., Accelerated evolution in the protein-coding regions is universal in crotalinae snake venom gland phospholipase A2 isozyme genes (1995) Proc. Natl. Acad. Sci. U.S.A., 92, pp. 5605-5609Ohno, M., Magenez, R., Ogawa, T., Molecular evolution of snake toxins: Is the functional diversity of snake toxins associated with a mechanism of accelerated evolution? (1998) Prog. Nucleic Acids Res. Mol. Biol., 59, pp. 309-364Afifiyan, F., Armugam, A., Tan, C.H., Gopalakrishnakone, P., Jeyaseelan, K., Postsynaptic alpha-neurotoxin gene of the spitting cobra, Naja naja sputatrix: Structure, organization, and phylogenetic analysis (1999) Genome Res., 9, pp. 259-266Tani, A., Ogawa, T., Nose, T., Characterization, primary structure and molecular evolution of anticoagulant protein from Agkistrodon actus venom (2002) Toxicon, 40, pp. 803-813Olivera, B.M., Walker, C., Cartier, G.E., Specification of cone snails and interspecific hyperdivergency of their venom peptides, potential evolutionary significance of introns (1999) Ann. N.Y. Acad. Sci., 870, pp. 223-237Chang, L., Lin, S., Huang, H., Hsiao, M., Genetic organization of alpha-bungarotoxins from Bungarus multicinctus (Taiwan banded krait): Evidence showing that the production of alpha-bungarotoxin isotoxins is not derived from edited mRNAs (1999) Nucleic Acids Res., 27, pp. 3970-3975Rádis-Baptista, G., Kubo, T., Oguiura, N., Identification of crotasin, a crotamine-related gene of Crotalus durissus terrificus (2004) Toxicon, 43, pp. 751-759Morrison, G.M., Semple, C.A., Kilanowski, F.M., Hill, R.D., Dorin, J.R., Signal sequence conservation and mature peptide divergence within subgroups of the murine beta-defensin gene family (2003) Mol. Biol. Evol., 20, pp. 460-470Sumiyama, K., Saitou, N., Ueda, S., Adaptive evolution of the IgA hinge region in primates (2002) Mol. Biol. Evol., 19, pp. 1093-1009Ohno, M., Chijiwa, T., Oda-Ueda, N., Ogawa, T., Hattori, S., Molecular evolution of myotoxic phospholipases A2 from snake venom (2003) Toxicon, 42, pp. 841-854Kanaji, S., Kanaji, T., Furihata, K., Kato, K., Ware, J.L., Kunicki, T.J., Convulxin binds to native, human glycoprotein Ib alpha (2003) J. Biol. Chem., 278, pp. 39,452-39,460Kassab, B.H., De Carvalho, D.D., Oliveira, M.A., Cloning, expression, and structural analysis of recombinant BJcuL, a c-type lectin from the Bothrops jararacussu snake venom (2004) Protein Expr. Purif., 35, pp. 344-352Jack, D.L., Turner, M.W., Anti-microbial activities of mannose-binding lectin (2003) Biochem. Soc. Trans., 31, pp. 753-757Geijtenbeek, T.B., Van Vliet, S.J., Engering, A.T., Hart, B.D., Van Kooyk, Y., Self- and nonself-recognition by C-type lectins on dendritic cells (2004) Annu. Rev. Immunol., 22, pp. 33-5

    Umbelliferone Induces Changes In The Structure And Pharmacological Activities Of Bn Iv, A Phospholipase A2 Isoform Isolated From Bothrops Neuwiedi

    No full text
    In this paper was demonstrated that umbelliferone induces changes in structure and pharmacological activities of Bn IV, a lysine 49 secretory phospholipase A2 (sPLA2) from Bothrops neuwiedi. Incubation of Bn IV with umbelliferone virtually abolished platelet aggregation, edema, and myotoxicity induced by native Bn IV. The amino acid sequence of Bn IV showed high sequence similarities with other Lys49 sPLA2s from B. jararacussu (BthTx-I), B. pirajai (PrTx-I), and B. neuwiedi pauloensis (Bn SP6 and Bn SP7). This sPLA2 also has a highly conserved C-terminal amino acid sequence, which has been shown as important for the pharmacological activities of Lys49 sPLA2. Sequencing of Bn IV previously treated with umbelliferone revealed modification of S(1) and S(20). Fluorescent spectral analysis and circular dichroism (CD) studies showed that umbelliferone modified the secondary structure of this protein. Moreover, the pharmacological activity of Bn IV is driven by synergism of the C-terminal region with the α-helix motifs, which are involved in substrate binding of the Asp49 and Lys49 residues of sPLA2 and have a direct effect on the Ca2+-independent membrane damage of some secretory snake venom PLA2. For Bn IV, these interactions are potentially important for triggering the pharmacological activity of this sPLA2. © 2011 Elsevier Ltd.576851860Chan, A.C., Pritchard, E.T., Gerrard, J.M., Man, R.Y., Choy, P.C., Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine) (1982) Biochim. Biophys. Acta., 713 (1), pp. 170-172Chioato, L., Ward, R.J., Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis (2003) Toxicon, 42 (8), pp. 869-883Chioato, L., Aragão, E.A., Lopes Ferreira, T., Medeiros, A.I., Faccioli, L.H., Ward, R.J., Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis (2007) Biochim. Biophys. Acta., 1768 (5), pp. 1247-1257Cintra, A.C., Marangoni, S., Oliveira, B., Giglio, J.R., Bothropstoxin-I: amino acid sequence and function (1993) J. Protein Chem., 12 (1), pp. 57-64Di Carlo, G., Mascolo, N., Izzo, A.A., Capasso, F., Flavonoids: old and new aspects of a class of natural therapeutic drugs (1999) Life Sci., 65, pp. 337-353dos Santos, M.L., Fagundes, F.H., Teixeira, B.R., Toyama, M.H., Aparicio, R., Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu (2008) Int. J. Mol. Sci., 9 (5), pp. 736-750Diz Filho, E.B., Marangoni, S., Toyama, D.O., Fagundes, F.H., Oliveira, S.C., Fonseca, F.V., Calgarotto, A.K., Toyama, M.H., Enzymatic and structural characterization of new PLA2 isoform isolated from white venom of Crotalus durissus ruruima (2009) Toxicon, 53 (1), pp. 104-114Fawzy, A.A., Vishwanath, B.S., Franson, R.C., Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action (1988) Agents Actions, 25, pp. 394-400Fonseca, F.V., Baldissera, L., Camargo, E.A., Antunes, E., Diz-Filho, E.B., Corrêa, A.G., Beriam, L.O., Toyama, M.H., Effect of the synthetic coumarin, ethyl 2-oxo-2H-chromene-3-carboxylate, on activity of Crotalus durissus ruruima sPLA2 as well as on edema and platelet aggregation induced by this factor (2010) Toxicon, 55 (8), pp. 1527-1530. , JFuly, A.L., Soares, A.M., Marcussi, S., Giglio, J.R., Guimar̃aes, J.A., Signal transduction pathways involved in the platelet aggregation induced by a D-49 phospholipase A2 isolated from Bothrops jararacussu snake venom (2004) Biochimie, 86, pp. 731-739Gil, B., Sanz, M.J., Terencio, M.C., Gunasegaran, R., Payá, M., Alcaraz, M.J., Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (1997) Biochem Pharmacol., 53 (5), pp. 733-740Ghani, U., Ng, K.K., Atta-ur-Rahman Choudhary, M.I., Ullah, N., James, M.N., Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin (2001) J Mol Biol., 314 (3), pp. 519-525Gutiérrez, J.M., Ownby, C.L., Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity (2003) Toxicon, 42 (8), pp. 915-931Hefner, Y., Borsch-Haubold, A.G., Murakami, M., Wilde, J.I., Pasquet, S., Schieltz, D., Ghomashchi, F., Gelb, M.H., Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases (2000) J. Biol. Chem., 275 (48), pp. 37542-37551Henrikson, R.L., Meredith, S.C., Amino acid analysis by reverse phase high performance liquid chromatography: pre-column derivatization with phenylisothiocyanate (1984) Anal. Biochem., 136, pp. 65-71Holland, J.A., Pritchard, K.A., Pappolla, M.A., Wolin, M.S., Rogers, N.J., Stemerman, M.B., Bradykinin induces superoxide anion release from human endothelial cells (1990) J. Cell Physiol., 143 (1), pp. 21-25Iglesias, C.V., Aparicio, R., Rodrigues-Simioni, L., Camargo, E.A., Antunes, E., Marangoni, S., Toyama, D.O., Toyama, M.H., Effects of morin on snake venom phospholipase A(2) (PLA(2) (2005) Toxicon, 46, pp. 751-758Kostova, I., Monolov, I., Karaivonova, M., Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives (2001) Arch. Pharm. (Weinheim), 334, pp. 157-162Kramer, R.M., Roberts, E.F., Manetta, J.V., Hyslop, P.A., Jakubowski, J.A., Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets (1993) J. Biol. Chem., 268, pp. 26796-26804Kramer, R.M., Roberts, E.F., Um, S.L., Börsch-Haubold, A.G., Watson, S.P., Fisher, M.J., Jakubowski, J.A., P38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2 (1996) J. Biol. Chem., 271 (44), pp. 27723-27729Kroll, M.H., Schafer, A.I., Biochemical mechanisms of platelet activation (1989) Blood, 74 (4), pp. 1181-1195Leung, L., Nachman, R., Molecular mechanisms of platelet aggregation (1986) Annu. Rev. Med., 37, pp. 179-186Lindahl, M., Tagesson, C., Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2 (1997) Inflammation, 21, pp. 347-356Lomonte, B., Angulo, Y., Calderón, L., An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action (2003) Toxicon, 42 (8), pp. 885-901Magro, A.J., Soares, A.M., Giglio, J.R., Fontes, M.R., Crystal structures of BnSP-7 and BnSP-6, two Lys49-phospholipases A(2): quaternary structure and inhibition mechanism insights (2003) Biochem. Biophys. Res. Comm., 311 (3), pp. 713-720Marshall, L.A., Chang, J.Y., Calhoun, W., Yu, J., Carlson, R.P., Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents (1989) J. Cell Biochem., 40 (2), pp. 147-155Massini, P., Lüscher, E.F., On the significance of the influx of calcium ions into stimulated human blood platelets (1976) Biochim Biophys Acta., 436 (3), pp. 652-663Murray, R.D., Coumarins (1989) Nat. Prod. Rep., 6, pp. 591-624Nirmal, N., Praba, G.O., Velmurugan, D., Modeling studies on phospholipase A2-inhibitor complexes (2008) Indian J. Biochem. Biophys., 45 (4), pp. 256-262Oliveira, C.F., Lopes, D.S., Mendes, M.M., Homsi-Brandeburgo, M.I., Hamaguchi, A., de Alcântara, T.M., Clissa, P.B., Rodrigues, V.M., Insights of local tissue damage and regeneration induced by BnSP-7, a myotoxin isolated from Bothrops (neuwiedi) pauloensis snake venom (2009) Toxicon, 53 (5), pp. 560-569Polgár, J., Kramer, R.M., Um, S.L., Jakubowski, J.A., Clemetson, K.J., Human group II 14 kDa phospholipase A2 activates human platelets (1997) Biochem. J, 327 (PART 1), pp. 259-265Puri, R.N., Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms (1998) Int. J. Biochem. Cell Biol., 30, pp. 1107-1122Qin, S., Pande, A.H., Nemec, K.N., Tatulian, S.A., The N-terminal alpha-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface (2004) J. Mol. Biol., 344 (1), pp. 71-89Qin, S., Pande, A.H., Nemec, K.N., He, X., Tatulian, S.A., Evidence for the regulatory role of the N-terminal helix of secretory phospholipase A(2) from studies on native and chimeric proteins (2005) J. Biol. Chem., 280 (44), pp. 36773-36783Rotelli, A.E., Guardia, T., Juárez, A.O., de la Rocha, N.E., Pelzer, L.E., Comparative study of flavonoids in experimental models of inflammation (2003) Pharmacol. Res., 48, pp. 601-606Schagger, H., von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa (1987) Anal. Biochem., 1, pp. 368-379Soares, A.M., Andrião-Escarso, S.H., Bortoleto, R.K., Rodrigues-Simioni, L., Arni, R.K., Ward, R.J., Gutiérrez, J.M., Giglio, J.R., Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom (2001) Arch. Biochem. Biophys., 387 (2), pp. 188-196Toyama, M.H., Soares, A.M., Vieira, C.A., Novello, J.C., Oliveira, B., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-I, a myotoxin from Bothrops pirajai snake venom, and its biological activity after alkylation with p-bromophenacyl bromide (1998) J. Protein Chem., 17 (7), pp. 713-718Toyama, M.H., Carneiro, E.M., Marangoni, S., Barbosa, R.L., Corso, G., Boschero, A.C., Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets (2000) Biochim. Biophys. Acta, 1474, pp. 56-60Toyama, M.H., Soares, A.M., Wen-Hwa, L., Polikarpov, I., Giglio, J.R., Marangoni, S., Amino acid sequence of piratoxin-II, a myotoxic lys49 phospholipase A(2) homologue from Bothrops pirajai venom (2000) Biochimie, 82 (3), pp. 245-250Toyama, M.H., de Oliveira, D.G., Beriam, L.O., Novello, J.C., Rodrigues-Simioni, L., Marangoni, S., Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom (2003) Toxicon, 41, pp. 1033-1038Toyama, M.H., Toyama, D.O., Joazeiro, P.P., Carneiro, E.M., Beriam, L.O.S., Marangoni, S., Boschero, A.C., Biological and structural characterization of a new PLA(2) from the Crotalus durissus collilineatus venom (2005) Protein J., 24, pp. 103-112Toyama, D.O., Marangoni, S., Diz-Filho, E.B., Oliveira, S.C., Toyama, M.H., Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom (2009) Toxicon, 53 (4), pp. 417-426Vincent, J.E., Zijlstra, F.J., Biphasic effects of phospholipase A2 on platelet aggregation. Effect of prostaglandin synthesis inhibitors and essential fatty acid deficiency (1976) Prostaglandins, 12 (6), pp. 971-979Vishwanath, B.S., Fawzy, A.A., Franson, R.C., Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid (1988) Inflammation, 12, pp. 549-56
    corecore